Results 191 to 200 of about 348,034 (261)
Dendritic Cell-T Cell Crosstalk Mediated Cancer Immunotherapy. [PDF]
Cai Y, Chen J, Li Y.
europepmc +1 more source
ABHD17C‐mediated depalmitoylation of BCL6B at Cys442 blocks its nuclear import and triggers ubiquitin‐dependent degradation, attenuating transcriptional repression of the anti‐phagocytic signal CD24. This mechanism enables pancreatic cancer cells to evade macrophage phagocytosis and fosters an immunosuppressive microenvironment.
Yalu Zhang +9 more
wiley +1 more source
A Nanobody-LNP Platform for Targeting and Relicensing Dendritic Cells for Potent Cancer Immunotherapy. [PDF]
Qin S +9 more
europepmc +1 more source
A non‐canonical core transcriptional regulatory circuit, composed of ID3, SMAD3, and NR2F2, drives Osimertinib resistance in non‐small cell lung cancer through super‐enhancer‐mediated activation of EPAS1, which couples neuroendocrine differentiation with ferroptosis evasion.
Aochu Liu +15 more
wiley +1 more source
Semaphorins: from CD8⁺ T cells to cancer immunotherapy. [PDF]
Liu Z, Wu Y, Xu P, Xu H, Yin K, Wang S.
europepmc +1 more source
A senolytic sonovaccine platform (SenoVac) is developed, in which senescent cell‐derived vesicles serve as broad senescent cell antigen reservior. The “2‐step” click chemistry strategy for effective lymph node delivery, and ultrasound‐triggered endosomal escape to boost cross‐presentation, ensures efficient senescent cell clearance and disease ...
Liang Zhang +10 more
wiley +1 more source
Decoding the spatiotemporal dynamics of tumor immune niche remodeling in cancer immunotherapy. [PDF]
Fu Z +11 more
europepmc +1 more source
A bandgap‐engineered PtxTey:Ag2Te quantum dot platform enables tunable NIR‐IIb emission for deep‐tissue imaging and mild photothermal therapy. Conjugation with αPD‐L1 confers dual tumor targeting and real‐time monitoring of PD‐L1 dynamics. Mild photothermal modulation induces immune reprogramming, enhancing checkpoint blockade efficacy and achieving ...
Jing Liu +9 more
wiley +1 more source
Nanomedicine-based cancer immunotherapy: translational barriers, mechanistic strategies, and future perspectives. [PDF]
Suo X, Liu Y, Zhang G, Li Y.
europepmc +1 more source

